• 1
    Agostini C, Chilosi M, Zambello R, Trentin L, Semenzato G. Pulmonary immune cells in health and disease: lymphocytes. Eur Respir J 1993;6:1378 1401.
  • 2
    Semenzato G, Bortolin M, Facco M, Tassinari C, Sancetta R, Agostini C. Lung lymphocytes: origin, biological functions, and laboratory techniques for their study in immune-mediated pulmonary disorders. Crit Rev Clin Lab Sci 1996;33:423 455.
  • 3
    Popper HH. Epithelioid cell granulomatosis of the lung: new insights and concepts. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:32 46.
  • 4
    Agostini C & Semenzato G. Immunology of idiopathic pulmonary fibrosis. Curr Opin Pulm Med 1996;2:364 369.
  • 5
    Agostini C, Siviero M, Semenzato G. Immune effector cells in idiopathic pulmonary fibrosis. Curr Opin Pulm Med 1997;3:348 355.
  • 6
    Pabst R, Schuster M, Tschernig T. Lymphocyte dynamics in the pulmonary microenvironment: implications for the pathophysiology of pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:197 202.
  • 7
    Mulligan MS, Vaporciyan AA, Warner RL, et al. Compartmentalized roles for leukocytic adhesion molecules in lung inflammatory injury. J Immunol 1995;154:1350 1363.
  • 8
    Lukacs NW & Ward PA. Inflammatory mediators, cytokines, and adhesion molecules in pulmonary inflammation and injury. Adv Immunol 1996;62:257 304.
  • 9
    Pinkston P, Bitterman PB, Crystal RG. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med 1983;308:793 800.
  • 10
    Semenzato G, Agostini C, Trentin L, et al. Evidence of cells bearing interleukin-2 receptor at sites of disease activity in sarcoid patients. Clin Exp Immunol 1984;57:331 337.
  • 11
    Agostini C, Trentin L, Facco M, et al. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol 1996;157:910 918.
  • 12
    Agostini C, Trentin L, Sancetta R, et al. Interleukin-15 triggers activation and growth of the CD8 T-cell pool in extravascular tissues of patients with acquired immunodeficiency syndrome. Blood 1997;90:1115 1123.
  • 13
    Lohmann-Matthes ML, Steinmuller C, Franke-Ullmann G. Pulmonary macrophages. Eur Respir J 1994;7:1678 1689.
  • 14
    Taylor ML, Noble PW, White B, Wise R, Liu MC, Bochner BS. Extensive surface phenotyping of alveolar macrophages in interstitial lung disease. Clin Immunol 2000;94:33 41.DOI: 10.1006/clim.1999.4803
  • 15
    Agostini C, Trentin L, Zambello R, et al. Pulmonary alveolar macrophages in patients with sarcoidosis and hypersensitivity pneumonitis: characterization by monoclonal antibodies. J Clin Immunol 1987;7:64 70.
  • 16
    Agostini C, Garbisa S, Trentin L, et al. Pulmonary alveolar macrophages from patients with active sarcoidosis express type IV collagenolytic proteinase. An enzymatic mechanism for influx of mononuclear phagocytes at sites of disease activity. J Clin Invest 1989;84:605 612.
  • 17
    Saltini C, Winestock K, Kirby M, Pinkston P, Crystal RG. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med 1989;320:1103 1109.
  • 18
    Semenzato G, Agostini C, Zambello R, et al. Activated T cells with immunoregulatory functions at different sites of involvement in sarcoidosis. Phenotypic and functional evaluations. Ann N Y Acad Sci 1986;465:56 73.
  • 19
    Moller DR. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:24 31.
  • 20
    Agostini C, Trentin L, Perin A, et al. Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process. Am J Physiol 1999;277:L240 250.
  • 21
    Agostini C, Zambello R, Facco M, et al. CD8 T-cell infiltration in extravascular tissues of patients with human immunodeficiency virus infection. Interleukin-15 upmodulates costimulatory pathways involved in the antigen-presenting cells-T-cell interaction. Blood 1999;93:1277 1286.
  • 22
    Kaneko Y, Kuwano K, Kunitake R, et al. Immunohistochemical localization of B7 costimulating molecules and major histocompatibility complex class II antigen in pulmonary sarcoidosis. Respiration 1999;66:343 348.
  • 23
    Nicod LP & Isler P. Alveolar macrophages in sarcoidosis coexpress high levels of CD86 (B7.2), CD40, and CD30L. Am J Respir Cell Mol Biol 1997;17:91 96.
  • 24
    Israel-Assayag E, Fournier M, Cormier Y. Blockade of T cell costimulation by CTLA4-Ig inhibits lung inflammation in murine hypersensitivity pneumonitis. J Immunol 1999;163:6794 6799.
  • 25
    Sibille Y & Marchandise FX. Pulmonary immune cells in health and disease: polymorphonuclear neutrophils. Eur Respir J 1993;6:1529 1543.
  • 26
    Shanley TP, Warner RL, Ward PA. The role of cytokines and adhesion molecules in the development of inflammatory injury. Mol Med Today 1995;1:40 45.
  • 27
    Car BD, Meloni F, Luisetti M, Semenzato G, Gialdroni-Grassi G, Walz A. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 1994;149:655 659.
  • 28
    Denis M & Ghadirian E. Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects. AIDS Res Hum Retroviruses 1994;10:1619 1627.
  • 29
    Keane MP, Arenberg DA, Lynch JP 3d, et al. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997;159:1437 1443.
  • 30
    Riise GC, Andersson BA, Kjellström C, et al. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant. Eur Respir J 1999;14:1123 1130.
  • 31
    Striz I, Mio T, Adachi Y, Robbins RA, Romberger DJ, Rennard SI. IL-4 and IL-13 stimulate human bronchial epithelial cells to release IL-8. Inflammation 1999;23:545 555.
  • 32
    Li L, Xia Y, Nguyen A, et al. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 1999;162:2477 2487.
  • 33
    Dong Q, Louahed J, Vink A, et al. IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice. Eur J Immunol 1999;29:2130 2139.DOI: 10.1002/(sici)1521-4141(199907)29:07<2130::aid-immu2130>;2-s
  • 34
    Brasier AR, Jamaluddin M, Casola A, Duan W, Shen Q, Garofalo RP. A promoter recruitment mechanism for tumor necrosis factor-alpha-induced interleukin-8 transcription in type II pulmonary epithelial cells. Dependence on nuclear abundance of Rel A, NF-kappaB1, and c-Rel transcription factors. J Biol Chem 1998;273:3551 3561.
  • 35
    Wallace WA & Howie SE. Immunoreactive interleukin 4 and interferon-gamma expression by type II alveolar epithelial cells in interstitial lung disease. J Pathol 1999;187:475 480.DOI: 10.1002/(sici)1096-9896(199903)187:4<475::aid-path268>;2-n
  • 36
    Hogaboam CM, Bone-Larson CL, Lipinski S, et al. Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models. J Immunol 1999;163:2193 2201.
  • 37
    Teran LM, Mochizuki M, Bartels J, et al. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am J Respir Cell Mol Biol 1999;20:777 786.
  • 38
    Agostini C & Semenzato G. Cytokines in sarcoidosis. Semin Respir Infect 1998;13:184 196.
  • 39
    Gruss HJ, Scott C, Rollins BJ, Brach MA, Herrmann F. Human fibroblasts express functional IL-2 receptors formed by the IL-2R alpha- and beta-chain subunits: association of IL-2 binding with secretion of the monocyte chemoattractant protein-1. J Immunol 1996;157:851 857.
  • 40
    Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Jasmin C, Canonica GW, Azzarone B. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int Immunol 1998;10:1421 1433.DOI: 10.1093/intimm/10.10.1421
  • 41
    Ando M, Miyazaki E, Fukami T, Kumamoto T, Tsuda T. Interleukin-4-producing cells in idiopathic pulmonary fibrosis: an immunohistochemical study. Respirology 1999;4:383 391.DOI: 10.1046/j.1440-1843.1999.00209.x
  • 42
    McLane MP, Haczku A, Van De Rijn M, et al. Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice. Am J Respir Cell Mol Biol 1998;19:713 720.
  • 43
    Temann UA, Geba GP, Rankin JA, Flavell RA. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med 1998;188:1307 1320.
  • 44
    Tinkle SS, Kittle LA, Newman LS. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease. J Immunol 1999;163:2747 2753.
  • 45
    Yamasaki H, Ando M, Brazer W, Center DM, Cruikshank WW. Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis. J Immunol 1999;163:3516 3523.
  • 46
    Hancock A, Armstrong L, Gama R, Millar A. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am J Respir Cell Mol Biol 1998;18:60 65.
  • 47
    Lentsch AB, Czermak BJ, Jordan JA, Ward PA. Regulation of acute lung inflammatory injury by endogenous IL-13. J Immunol 1999;162:1071 1076.
  • 48
    Zhu Z, Homer RJ, Wang Z, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779 788.
  • 49
    Robinson BW, McLemore TL, Crystal RG. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 1985;75:1488 1495.
  • 50
    Bergeron A, Bonay M, Kambouchner M, et al. Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. J Immunol 1997;159:3034 3043.
  • 51
    Muller-Quernheim J, Pfeifer S, Mannel D, Strausz J, Ferlinz R. Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis 1992;145:187 192.
  • 52
    Agostini C, Cassatella M, Zambello R, et al. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. J Immunol 1998;161:6413 6420.
  • 53
    Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997;18:263 266.DOI: 10.1016/s0167-5699(97)01070-0
  • 54
    Wallace WA, Ramage EA, Lamb D, Howie SE. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin Exp Immunol 1995;101:436 441.
  • 55
    Agostini C, Zambello R, Trentin L, Semenzato G. HIV and pulmonary immune responses. Immunol Today 1996;17:359 364.DOI: 10.1016/0167-5699(96)10013-x
  • 56
    Mikuniya T, Nagai S, Shimoji T, et al. Quantitative evaluation of the IL-1 beta and IL-1 receptor antagonist obtained from BALF macrophages in patients with interstitial lung diseases. Sarcoidosis Vasc Diffuse Lung Dis 1997;14:39 45.
  • 57
    Denis M. Interleukin-1 (IL-1) is an important cytokine in granulomatous alveolitis. Cell Immunol 1994;157:70 80.DOI: 10.1006/cimm.1994.1206
  • 58
    Janson RW, King Te Jr, Hance KR, Arend WP. Enhanced production of IL-1 receptor antagonist by alveolar macrophages from patients with interstitial lung disease. Am Rev Respir Dis 1993;148:495 503.
  • 59
    Zhang Y, Lee TC, Guillemin B, Yu MC, Rom WN. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol 1993;150:4188 4196.
  • 60
    Magnan A, Mege JL, Escallier JC, et al. Balance between alveolar macrophage IL-6 and TGF-beta in lung-transplant recipients. Marseille and Montreal Lung Transplantation Group. Am J Respir Crit Care Med 1996;153:1431 1436.
  • 61
    Vanhee D, Gosset P, Marquette CH, et al. Secretion and mRNA expression of TNF alpha and IL-6 in the lungs of pneumoconiosis patients. Am J Respir Crit Care Med 1995;152:298 306.
  • 62
    Denis M. Interleukin-6 in mouse hypersensitivity pneumonitis: changes in lung free cells following depletion of endogenous IL-6 or direct administration of IL-6. J Leukoc Biol 1992;52:197 201.
  • 63
    Tinkle SS & Newman LS. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease. Am J Respir Crit Care Med 1997;156:1884 1891.
  • 64
    Ishioka S, Saito T, Hiyama K, et al. Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor-B and granulocyte-macrophage colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1996;13:139 145.
  • 65
    Crestani B, Seta N, De Bandt M, et al. Interleukin 6 secretion by monocytes and alveolar macrophages in systemic sclerosis with lung involvement. Am J Respir Crit Care Med 1994;149:1260 1265.
  • 66
    Yoshida M, Sakuma J, Hayashi S, et al. A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene. Proc Natl Acad Sci U S A 1995;92:9570 9574.
  • 67
    Zhang M, Gately MK, Wang E, et al. Interleukin 12 at the site of disease in tuberculosis. J Clin Invest 1994;93:1733 1739.
  • 68
    Taha RA, Minshall EM, Olivenstein R, et al. Increased expression of IL-12 receptor mRNA in active pulmonary tuberculosis and sarcoidosis. Am J Respir Crit Care Med 1999;160:1119 1123.
  • 69
    Munk ME, Mayer P, Anding P, Feldmann K, Kaufmann SH. Increased numbers of interleukin-12-producing cells in human tuberculosis. Infect Immun 1996;64:1078 1080.
  • 70
    Gudmundsson G, Monick MM, Hunninghake GW. IL-12 modulates expression of hypersensitivity pneumonitis. J Immunol 1998;161:991 999.
  • 71
    Rogge L, Papi A, Presky DH, et al. Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo. J Immunol 1999;162:3926 3932.
  • 72
    Zissel G, Baumer I, Schlaak M, Muller-Quernheim J. In vitro release of interleukin-15 by broncho-alveolar lavage cells and peripheral blood mononuclear cells from patients with different lung diseases. Eur Cytokine Netw 2000;11:105 112.
  • 73
    Cameron LA, Taha RA, Tsicopoulos A, et al. Airway epithelium expresses interleukin-18. Eur Respir J 1999;14:553 559.
  • 74
    Kreipe H, Radzun HJ, Heidorn K, et al. Proliferation, macrophage colony-stimulating factor, and macrophage colony-stimulating factor-receptor expression of alveolar macrophages in active sarcoidosis. Lab Invest 1990;62:697 703.
  • 75
    Itoh A, Yamaguchi E, Kuzumaki N, et al. Expression of granulocyte-macrophage colony-stimulating factor mRNA by inflammatory cells in the sarcoid lung. Am J Respir Cell Mol Biol 1990;3:245 249.
  • 76
    Enthammer C, Zambello R, Trentin L, et al. Synthesis and release of granulocyte-macrophage colony stimulating factor by alveolar macrophages of patients with sarcoidosis. Sarcoidosis 1993;10:147 148.
  • 77
    Agostini C, Trentin L, Zambello R, et al. Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1-infected patients. A mechanism accounting for macrophage and neutrophil accumulation. J Immunol 1992;149:3379 3385.
  • 78
    Baughman RP, Lower EE, Miller MA, Bejarano PA, Heffelfinger SC. Overexpression of transforming growth factor-alpha and epidermal growth factor-receptor in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:57 61.
  • 79
    Zhang K & Phan SH. Cytokines and pulmonary fibrosis. Biol Signals 1996;5:232 239.
  • 80
    Jagirdar J, Begin R, Dufresne A, Goswami S, Lee TC, Rom WN. Transforming growth factor-beta (TGF-beta) in silicosis. Am J Respir Crit Care Med 1996;154:1076 1081.
  • 81
    Israel-Biet D, Cadranel J, Beldjord K, Andrieu JM, Jeffrey A, Even P. Tumor necrosis factor production in HIV-seropositive subjects. Relationship with lung opportunistic infections and HIV expression in alveolar macrophages. J Immunol 1991;147:490 494.
  • 82
    Bost TW, Riches DW, Schumacher B, et al. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta. Am J Respir Cell Mol Biol 1994;10:506 513.
  • 83
    Agostini C, Zambello R, Sancetta R, et al. Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. Am J Respir Crit Care Med 1996;153:1359 1367.
  • 84
    Dai H, Guzman J, Costabel U. Increased expression of apoptosis signalling receptors by alveolar macrophages in sarcoidosis. Eur Respir J 1999;13:1451 1454.
  • 85
    Dai H, Guzman J, Bauer PC, Costabel U. Elevated levels of soluble TNF receptors in bronchoalveolar lavage fluid in extrinsic allergic alveolitis. Clin Exp Allergy 1999;29:1209 1213.DOI: 10.1046/j.1365-2222.1999.00632.x
  • 86
    Agostini C, Perin A, Semenzato G. Cell apoptosis and granuloma lung diseases. Curr Opin Pulm Med 1998;4:261 266.
  • 87
    Baggiolini M. Chemokines and leukocyte traffic. Nature 1998;392:565 568.
  • 88
    Luster A. Chemokines – chemotactic cytokines that mediate inflammation. N Engl J Med 1998;228:436 445.
  • 89
    Murphy PM, Baggiolini M, Charo IF, et al. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000;52:145 176.
  • 90
    Semenzato G. Chemotactic cytokines: from the molecular level to clinical use. Sarcoidosis Vasc Diffuse Lung Dis 1998;15:131 133.
  • 91
    Iyonaga K, Suga M, Ichiyasu H, Yamamoto T, Hiraga Y, Ando M. Measurement of serum monocyte chemoattractant protein-1 and its clinical application for estimating the activity of granuloma formation in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1998;15:165 172.
  • 92
    Kodama N, Yamaguchi E, Hizawa N, et al. Expression of RANTES by bronchoalveolar lavage cells in nonsmoking patients with interstitial lung diseases. Am J Respir Cell Mol Biol 1998;18:526 531.
  • 93
    Hashimoto S, Nakayama T, Gon Y, et al. Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1alpha (MIP-1alpha) levels with disease activity and clinical course of sarcoidosis. Clin Exp Immunol 1998;111:604 610.DOI: 10.1046/j.1365-2249.1998.00519.x
  • 94
    Devergne O, Marfaing-Koka A, Schall TJ, et al. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med 1994;179:1689 1694.
  • 95
    Agostini C, Siviero M, Facco M, et al. CXC chemokines IP-10 and Mig are expressed and direct migration of pulmonary CD8+/CXCR3+ T cells in the lung of patients with HIV infection and T-cell alveolitis. Am J Respir Crit Care Med 2000 (in press).
  • 96
    Sauty A, Dziejman M, Taha RA, et al. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol 1999;162:3549 3558.
  • 97
    Brieland JK, Jones ML, Flory CM, et al. Expression of monocyte chemoattractant protein-1 (MCP-1) by rat alveolar macrophages during chronic lung injury. Am J Respir Cell Mol Biol 1993;9:300 305.
  • 98
    Smith RE, Strieter RM, Phan SH, Lukacs N, Kunkel SL. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury. J Leukoc Biol 1998;64:528 536.
  • 99
    Hasegawa M, Sato S, Takehara K. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis. Clin Exp Immunol 1999;117:159 165.DOI: 10.1046/j.1365-2249.1999.00929.x
  • 100
    Suga M, Iyonaga K, Ichiyasu H, Saita N, Yamasaki H, Ando M. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Eur Respir J 1999;14:376 382.
  • 101
    Yoshimoto T, Wang CR, Yoneto T, Matsuzawa A, Cruikshank WW, Nariuchi H. Role of IL-16 in delayed-type hypersensitivity reaction. Blood 2000;95:2869 2874.
  • 102
    Center DM, Kornfeld H, Cruikshank WW. Interleukin 16 and its function as a CD4 ligand. Immunol Today 1996;17:476 481.DOI: 10.1016/0167-5699(96)10052-i
  • 103
    O'regan AW, Chupp GL, Lowry JA, Goetschkes M, Mulligan N, Berman JS. Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J Immunol 1999;162:1024 1031.
  • 104
    Tani K, Ogushi F, Huang L, et al. CD13/aminopeptidase N, a novel chemoattractant for T lymphocytes in pulmonary sarcoidosis. Am J Respir Crit Care Med 2000;161:1636 1642.
  • 105
    Smith RE, Strieter RM, Zhang K, et al. A role for C-C chemokines in fibrotic lung disease. J Leukoc Biol 1995;57:782 787.
  • 106
    Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:149 173.
  • 107
    Agostini C, Semenzato G, James DG. Immunological, clinical and molecular aspects of sarcoidosis. Mol Aspects Med 1997;18:91 165.DOI: 10.1016/s0098-2997(97)84114-3
  • 108
    Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;336:1224 1234.
  • 109
    Mizuki M, Eklund A, Grunewald J. Altered expression of natural killer cell inhibitory receptors (KIRs) on T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2000;17:54 59.
  • 110
    Trentin L, Zambello R, Facco M, et al. Selection of T lymphocytes bearing limited TCR-Vbeta regions in the lung of hypersensitivity pneumonitis and sarcoidosis. Am J Respir Crit Care Med 1997;155:587 596.
  • 111
    Moller DR. T-cell receptor genes in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1998;15:158 164.
  • 112
    Grunewald J, Janson CH, Eklund A, et al. Restricted V alpha 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur J Immunol 1992;22:129 135.
  • 113
    Cerutti A, Trentin L, Zambello R, et al. Selection of Valpha 2.3 cells in the lung of patients with sarcoidosis. Sarcoidosis 1993;10:165 166.
  • 114
    Zaiss AW, Costabel U, Wagner DJ, Baur R, Ruhle KH, Matthys H. T4/T8 ratio in bronchoalveolar lavage fluid: sensitivity and specificity for the diagnosis of sarcoidosis. Prax Klin Pneumol 1988;42:233 234.
  • 115
    Costabel U. CD4/CD8 ratios in bronchoalveolar lavage fluid: of value for diagnosing sarcoidosis? Eur Respir J 1997;10:2699 2700.
  • 116
    Agostini C, Trentin L, Zambello R, et al. CD8 alveolitis in sarcoidosis: incidence, phenotypic characteristics, and clinical features. Am J Med 1993;95:466 472.
  • 117
    Striz I, Zheng L, Wang YM, Pokorna H, Bauer PC, Costabel U. Soluble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD14. Am J Respir Crit Care Med 1995;151:544 547.
  • 118
    Zheng L, Teschler H, Guzman J, Hubner K, Striz I, Costabel U. Alveolar macrophage TNF-alpha release and BAL cell phenotypes in sarcoidosis. Am J Respir Crit Care Med 1995;152:1061 1066.
  • 119
    Saltini C, Markam TN, Jones Williams SW. Chronic beryllium disease. In: WaltersEH, Du BoisRM, editors. Immunology and management of interstitial lung diseases. London: Chapman & Hall, 1995:123 144.
  • 120
    Kreiss K, Wasserman S, Mroz MM, Newman LS. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations. J Occup Med 1993;35:267 274.
  • 121
    Fenton MJ & Vermeulen MW. Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect Immun 1996;64:683 690.
  • 122
    Orme IM, Roberts AD, Griffin JP, Abrams JS. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 1993;151:518 525.
  • 123
    Orme IM, Andersen P, Boom WH. T cell response to Mycobacterium tuberculosis. J Infect Dis 1993;167:1481 1497.
  • 124
    Balaji KN, Schwander SK, Rich EA, Boom WH. Alveolar macrophages as accessory cells for human gamma delta T cells activated by Mycobacterium tuberculosis. J Immunol 1995;154:5959 5968.
  • 125
    Wallis RS & Ellner JJ. Cytokines and tuberculosis. J Leukoc Biol 1994;55:676 681.
  • 126
    Roach TI, Barton CH, Chatterjee D, Blackwell JM. Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha . J Immunol 1993;150:1886 1896.
  • 127
    Selman M. Hypersensitivity pneumonitis. In: SchwarzMI, KingTeJr, editors. Interstitial lung disease. 3rd ed. London: BC Dekker, 1998:393 422.
  • 128
    Semenzato G & Trentin L. Extrinsic allergic alveolitis. In: WaltersEH, Du BoisRM, editors. Immunology and management of interstitial lung diseases. London: Chapman & Hall, 1995:131 148.
  • 129
    Trentin L, Marcer G, Chilosi M, et al. Longitudinal study of alveolitis in hypersensitivity pneumonitis patients: an immunologic evaluation. J Allergy Clin Immunol 1988;82:577 585.
  • 130
    Shigematsu M, Nagai S, Nishimura K, Izumi T, Eklund AG, Grunewald J. Summer-type hypersensitivity pneumonitis. T-cell receptor V gene usage in BALF T-cells from 3 cases in one family. Sarcoidosis Vasc Diffuse Lung Dis 1998;15:173 177.
  • 131
    Cormier Y, Belanger J, Laviolette M. Prognostic significance of bronchoalveolar lymphocytosis in farmer's lung. Am Rev Respir Dis 1987;135:692 695.
  • 132
    Plata F, Autran B, Martins LP, et al. AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature 1987;328:348 351.
  • 133
    Trentin L, Zambello R, Facco M, et al. Skewing of the T-cell receptor repertoire in the lung of patients with HIV-1 infection. AIDS 1996;10:729 737.
  • 134
    Semenzato G, Agostini C, Chieco-Bianchi L, De Rossi A. HIV load in highly purified CD8+ T cells retrieved from pulmonary and blood compartments. J Leukoc Biol 1998;64:298 301.
  • 135
    Semenzato G, Agostini C, Ometto L, et al. CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1. Blood 1995;85:2308 2314.
  • 136
    Agostini C, Adami F, Poulter LW, et al. Role of bronchoalveolar lavage in predicting survival of patients with human immunodeficiency virus infection. Am J Respir Crit Care Med 1997;156:1501 1507.
  • 137
    Agostini C, Zambello R, Trentin L, et al. Cytotoxic events taking place in the lung of patients with HIV-1 infection. Evidence of an intrinsic defect of the major histocompatibility complex-unrestricted killing partially restored by the incubation with rIL-2. Am Rev Respir Dis 1990;142:516 522.
  • 138
    Agostini C, Zambello R, Trentin L, et al. Gamma delta T cell receptor subsets in the lung of patients with HIV-1 infection. Cell Immunol 1994;153:194 205.DOI: 10.1006/cimm.1994.1017
  • 139
    Sadat-Sowti B, Parrot A, Quint L, Mayaud C, Debre P, Autran B. Alveolar CD8+ CD57+ lymphocytes in human immunodeficiency virus infection produce an inhibitor of cytotoxic functions. Am J Respir Crit Care Med 1994;149:972 980.
  • 140
    Twigg HL, Iwamoto GK, Soliman DM. Role of cytokines in alveolar macrophage accessory cell function in HIV-infected individuals. J Immunol 1992;149:1462 1469.
  • 141
    Reinsmoen NL, Bolman RM, Savik K, Butters K, Hertz M. Differentiation of class I- and class II-directed donor-specific alloreactivity in bronchoalveolar lavage lymphocytes from lung transplant recipients. Transplantation 1992;53:181 189.
  • 142
    Arcasoy SM & Kotloff RM. Lung transplantation. N Engl J Med 1999;340:1081 1091.
  • 143
    Rabinowich H, Zeevi A, Paradis IL, et al. Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients. Transplantation 1990;49:115 121.
  • 144
    Monti G, Magnan A, Fattal M, et al. Intrapulmonary production of RANTES during rejection and CMV pneumonitis after lung transplantation. Transplantation 1996;61:1757 1762.
  • 145
    Zeevi A, Rabinowich H, Yousem SA, et al. Presence of donor-specific alloreactivity in histologically normal lung allografts is predictive of subsequent bronchiolitis obliterans. Transplant Proc 1991;23:1128 1129.
  • 146
    King Te Jr. Connective tissue diseases. In: SchwarzMI, KingTeJr, editors. Interstitial lung disease. London: BC Dekker, 1998:551 505.
  • 147
    Kolarz G, Scherak O, Popp W, et al. Bronchoalveolar lavage in rheumatoid arthritis. Br J Rheumatol 1993;32:556 561.
  • 148
    Groen H, Aslander M, Bootsma H, Van Der Mark TW, Kallenberg CG, Postma DS. Bronchoalveolar lavage cell analysis and lung function impairment in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1993;94:127 133.
  • 149
    Pesci A, Bertorelli G, Manganelli P, Ambanelli U. Bronchoalveolar lavage analysis of interstitial lung disease in CREST syndrome. Clin Exp Rheumatol 1986;4:121 124.
  • 150
    Behr J, Vogelmeier C, Beinert T, et al. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Am J Respir Crit Care Med 1996;154:400 406.
  • 151
    Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990;141:727 733.
  • 152
    Dalavanga YA, Constantopoulos SH, Galanopoulou V, Zerva L, Moutsopoulos HM. Alveolitis correlates with clinical pulmonary involvement in primary Sjögren's syndrome. Chest 1991;99:1394 1397.